Mandate

Vinge advises Borevind AB (publ) in connection with issue in kind

July 05, 2010

Vinge has advised Borevind in connection with an issue in kind regarding the entire issued shares of GenerPro AB and Energi Tekknik AS. Borevind invests in and improves unlisted companies which conduct operations relating to renewable energy and improvement of energy efficiency. Borevind’s shares are traded on NASDAQ OMX First North. GenerPro manufactures and renovates, among other things, generators and steam turbines for the power industry. The operations are conducted in Västerås. Energi Teknikk develops, manufactures and supplies small hydropower plants. The operations are conducted in Dimmelsvik in Norway.

Vinge’s team primarily consisted of associates Magnus Pauli, Anna Björk Larsson and Tove Rosén Johansson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026